Cargando…

NF1-like optic pathway gliomas in children: clinical and molecular characterization of this specific presentation

BACKGROUND: Pediatric neurofibromatosis type 1 (NF1)–associated optic pathway gliomas (OPGs) exhibit different clinico-radiological features, treatment, and outcome compared with sporadic OPGs. While NF1-associated OPGs are caused by complete loss-of-function of the NF1 gene, other genetic alteratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lobón-Iglesias, María Jesús, Laurendeau, Ingrid, Guerrini-Rousseau, Léa, Tauziède-Espariat, Arnault, Briand-Suleau, Audrey, Varlet, Pascale, Vidaud, Dominique, Vidaud, Michel, Brugieres, Laurence, Grill, Jacques, Pasmant, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317061/ https://www.ncbi.nlm.nih.gov/pubmed/32642735 http://dx.doi.org/10.1093/noajnl/vdz054

Ejemplares similares

Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities
por: Gilbert-Dussardier, Brigitte, et al.
Publicado: (2016)

One NF1 Mutation may Conceal Another
por: Pacot, Laurence, et al.
Publicado: (2019)

HGG-40. NF1 mosaicism in a CMMRD-patient with a glioblastoma
por: Guerrini-Rousseau, Lea, et al.
Publicado: (2022)

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
por: Pereira, Victor, et al.
Publicado: (2021)

MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
por: Masliah-Planchon, Julien, et al.
Publicado: (2013)

Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Neurofibromatosis Type 1 Molecular Diagnosis: The RNA Point of View
por: Pasmant, Eric, et al.
Publicado: (2016)

Pediatric meningiomas: A literature review and diagnostic update
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas
por: Tlemsani, Camille, et al.
Publicado: (2019)

Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells
por: Varin, Jennifer, et al.
Publicado: (2016)

Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR
por: Lévy, Pascale, et al.
Publicado: (2004)

Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
por: Huybrechts, Sophie, et al.
Publicado: (2020)

RAS MAPK inhibitors deregulation in leukemia
por: Pasmant, Eric, et al.
Publicado: (2015)

NF2 and ZFTA evaluation in the diagnostic algorithm of pediatric posterior fossa ependymoma with H3K27ME3 retained expression
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

ATRT-27. COST-EFFECTIVE ASSAYS TO SUBGROUP ATRT IN THE DAILY ROUTINE
por: Lobon-Iglesias, María-Jesús, et al.
Publicado: (2020)

Deep intronic hotspot variant explaining rhabdoid tumor predisposition syndrome in two patients with atypical teratoid and rhabdoid tumor
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2017)

Significant gene expression differences in histologically “Normal” liver biopsies: Implications for control tissue
por: Asselah, Tarik, et al.
Publicado: (2008)

Severe Phenotype in Patients with Large Deletions of NF1
por: Pacot, Laurence, et al.
Publicado: (2021)

Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2020)

DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
por: Castel, David, et al.
Publicado: (2020)

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant‐type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2023)

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
por: Tauziède-Espariat, A., et al.
Publicado: (2019)

Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis
por: Roux, Alexandre, et al.
Publicado: (2021)

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
por: Antin, C., et al.
Publicado: (2020)

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis
por: Mariet, Cassandra, et al.
Publicado: (2022)

Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data
por: Sabbagh, Audrey, et al.
Publicado: (2009)

Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion
por: Métais, Alice, et al.
Publicado: (2023)

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
por: Tauziède-Espariat, A., et al.
Publicado: (2020)

DIPG-38. PATIENT-DERIVED THREE-DIMENSIONAL AVATARS REVEAL CELL-AUTONOMOUS MECHANISMS DRIVING INVASION AND METASTATIC PROGRESSION IN DIFFUSE MIDLINE GLIOMAS
por: Bruschi, Marco, et al.
Publicado: (2023)

Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

A malignant choroid plexus tumour with prevailing immature blastematous elements
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

Diagnostic accuracy of a minimal immunohistochemical panel in at/rt molecular subtyping, correlated to dna-methylation profiling
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

Identification of the first intragenic deletion of the PITX2 gene causing an Axenfeld-Rieger Syndrome: case report
por: de la Houssaye, Guillaume, et al.
Publicado: (2006)

A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Development of a Machine Learning Classifier Based on Radiomic Features Extracted From Post-Contrast 3D T1-Weighted MR Images to Distinguish Glioblastoma From Solitary Brain Metastasis
por: de Causans, Alix, et al.
Publicado: (2021)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b87ijifd3dtl0mdvfhqjs5b87b